However, despite its promising potential as a treatment tool for various brain diseases, efforts to use BDNF in the treatment of neurological diseases have complicated problems of application because BDNF has a short half-life (within 10 min) and is unable to cross the blood-brain barrier (BBB) due to its large size (27 kDa) [24]. This evidence concerns the gene BDNF and brain disorder.